跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
卢美根 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Bimatoprost Ophthalmic Solution
Approved
化学药品
Bimatoprost Ophthalmic Solution
AbbVie Deutschland GmbH & Co. KG
🇨🇳 National Medical Products Administration
Approval Date
Jun 10, 2020
Approval ID
7MazXcP1Ihz
Company
AbbVie Deutschland GmbH & Co. KG
Type
化学药品
Approval Details
Approval Id
7MazXcP1Ihz
Approval Number
H20150484
Generic Name
贝美前列素滴眼液
Generic Name En
Bimatoprost Ophthalmic Solution
Trade Name
卢美根
Brand Name
卢美根
Drug Type
化学药品
Dosage Form
眼用制剂
Strength
3ml:0.9mg
Reg Date
2020-06-10
Expired Date
2025-06-09
Company Name
AbbVie Deutschland GmbH & Co. KG
Company Address
Knollstrasse,67061 Ludwigshafen, Germany
Production Company Name
Allergan Pharmaceuticals Ireland
Production Company Address
Castlebar Road, Westport, County Mayo, Ireland
Company Detail Path
/organization/abbvie-deutschland-gmbh-and-co-kg
Production Company Detail Path
/organization/allergan-pharmaceuticals-ireland
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jun 10, 2020
Approval ID
7MazXcP1Ihz
Type
化学药品
Back to NMPA Approvals